ArticleJournal of clinical medicine2026

A Multi-Targeted Strategy for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: Real-World Outcomes of the ViPOR Regimen.

Süreyya Yiğit Kaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.